Rise of sodium-glucose cotransporter 2 inhibitors in the management of nonalcoholic fatty liver dise

• 作 者: Amr Dokmak Mohammad Almeqdadi
• 机 构: DivisionofMedicine,TuftsUniversitySchoolofMedicine,DivisionofGastroenterology,DivisionofGastroentero
• 出 处: 世界肝病学杂志:英文版(电子版)
• 发表日期: 2019年7期
• 关键词: Non-alcoholic fatty LIVER disease Non-alcoholic steatohepatitis Sodiumglucose CO

Non-alcoholic fatty liver disease (NAFLD) is the most common form of chronic liver disease in the Western world. It is more prevalent in male gender, and with increasing age, obesity, and insulin resistance. Besides weight loss, there are limited treatmen